Abstract Citation-based indicators are often used to help evaluate the impact of published medical studies, even though the research has the ultimate goal of improving human wellbeing. One direct way of influencing health outcomes is by guiding physicians and other medical professionals about which drugs to prescribe. A high profile source of this guidance is the AHFS DI Essentials product of the American Society of Health-System Pharmacists, which gives systematic information for drug prescribers. AHFS DI Essentials documents, which are also indexed by Drugs.com, include references to academic studies and the referenced work is therefore helping patients by guiding drug prescribing. This article extracts AHFS DI Essentials documents from Drugs.com and assesses whether articles referenced in these information sheets have their value recognised by higher Scopus citation counts. A comparison of mean log-transformed citation counts between articles that are and are not referenced in AHFS DI Essentials shows that AHFS DI Essentials references are more highly cited than average for the publishing journal. This suggests that medical research influencing drug prescribing is more cited than average.
Introduction
Citation counts are important in medical fields to help research evaluation. In the UK Research Excellence Framework (REF) 2014 , although only 11 of the 36 disciplinary areas into which all research was categorised drew upon citation counts, these 11 included Clinical Medicine and the two other health fields (Wilsdon et al. 2015) . Citations counts and related indicators, such as Journal Impact Factors and the h-index, may also be used in appointments, promotion, tenure and funding decisions (e.g., Curry 2012; Feder and Madara 2008) , although various bodies have outlawed some or all of these (Schekman and Patterson 2013) . Citation counts have well-known limitations because they do not directly measure research value. In particular, applied research can be useful for non-academics that do not cite it and so can be undervalued by traditional citation counts (e.g., biomedical research: Lewison and Dawson 1998) . It is therefore important to seek other indicators for different types of research value (Priem et al. 2010) including in the medical sciences (Barbic et al. 2016; Scarlat et al. 2015) . One way in which medical research can be useful is by influencing medicine prescribing by clinicians. Although previous studies have shown that it is possible to get evidence of clinical impact from citations in UK health professional guidelines (Grant 1999; Grant et al. 2000; Kryl et al. 2012 ; Lewison and Sullivan 2008; Thelwall and Maflahi 2016) and indirectly from mainly U.S.-based clinical trials (Thelwall and Kousha 2016) , additional sources of evidence are needed for a more complete picture, including for the key step of drug prescribing.
In the biomedical field, citations in various forms are widely used in research evaluation. These include simple citation counts, Journal Impact Factors (JIFs) and the h-index, despite the acknowledged limitations of all of these. The importance of using some form of citation analysis for biomedical research has been implicitly acknowledge by the creation of a new indicator, The Relative Citation Ratio (RCR), by the Office of Portfolio Analysis, National Institutes of Health (Hutchins et al. 2016) . The purpose of the RCR is to overcome many of the limitations of other indicators through the use of a complex algorithm to minimise the risk that articles are unfairly treated in citation comparisons. Nevertheless, citation-based algorithms cannot measure the clinical value of research. It role is to support rather than replace expert judgements.
The American Society of Health-System Pharmacists (ASHP) is a professional association to provide support for, and advocacy on behalf of, pharmacists in hospitals and other parts of the health system in the U.S.A. It produces, amongst other things, ''an evidence-based foundation for safe and effective drug therapy'' (www.ashp.org/menu/ AboutUs/WhatWeDo). Its key product for practitioners is AHFS DI Essentials, which gives a range of information about drugs to inform decisions about whether to prescribe them and how to identify problems with patients taking them. This appears to be an independent evidence-based source of drug information because ASHP publishes clear guidelines for this (http://www.ahfsdruginformation.com/editorial-independence/). Each medication has a self-contained document (called a monograph) that is underpinned by traditional academic references through a reference list at the end. The documents are intended to support prescribing in the U.S.A. but, through their hosting on the website drugs.com, also reach an international audience. Drugs.com was the most popular pharmacy website in the world, according to Alexa.com in December 2016 (http://www.alexa. com/topsites/category/Top/Health/Pharmacy), with half (48.5%) of its visitors originating from the U.S.A., but India, the UK, Canada and Australia also having substantial numbers of users (http://www.alexa.com/siteinfo/drugs.com).
Because of its authoritative origins and the presence of references, AHFS DI Essentials is a suitable new source of evidence about scholarly articles that have had an impact on prescribing practices. In contrast to the free online UK NICE Guidelines (Thelwall and Maflahi 2016) , it focuses on drugs rather than illnesses, and is not an official national source of information. Nevertheless, its extensive and focused collection of medical references is potentially useful as applied medical impact evidence. There are other similar national sources of drug information, such as the British National Formulary (BNF) pharmaceutical reference book from the UK's Royal Pharmaceutical Society and British Medical Association, and Martindale: The Complete Drug Reference from the UK's Royal Pharmaceutical Society publishing house, but AHFS DI Essentials is one of the few that is free online.
Research questions
Articles referenced in AHFS DI Essentials apparently have a direct impact on prescribing practice in the U.S.A. and therefore successfully achieve the main goal of medical research: improving health outcomes. Nevertheless, the authors of the referenced articles are likely to be evaluated by the publishing venue (the perceived value of the journal) or their citation counts in the form of a h-index or a total citation count. If articles referenced in AHFS DI Essentials tend not to be highly cited, then the contributions of their authors would be undervalued in research evaluations. This is possible because basic medical research attracts citations from both basic and applied research, whereas applied research attracts few basic citations in medicine (Narin et al. 1976) . Hence the main research question is to check whether the traditional research evaluation source of quantitative evidence, academic citations, undervalues AHFS DI Essentials references.
• Are articles referenced in AHFS DI Essentials less cited than average?
Methods
The overall research design was to extract all references from AHFS DI Essentials, identify the most cited journals, and compare the citation counts of the AHFS DI Essentials references in these journals with the remaining articles to see if they tend to be more cited. Although a more standard approach would be to compare papers within individual Scopus or Web of Science fields rather than within individual journals, a journal-based approach is preferable for greater specificity. In particular, several important medical journals are generalist (e.g., NEJM, Lancet, JAMA) and therefore not amenable to fine-grained field categorisation. In contrast, a focus on journals allows the finest grained classification possible (at least for any journal-based classification scheme, c.f.: Small et al. 1985) without the possibility that the results are tainted by inappropriate or multiple journal classifications. Another advantage is that medical professionals may focus on specific high impact journals (as claimed by: Goldacre 2009), which may distort the relationship between the value of an article and the number of times it is cited, undermining field-wide analyses. Two disadvantages of a focus on journals are reduced statistical power from fewer articles to analyse in each individual test and reduced statistical power from losing the differentiation between higher and lower average quality journals in the same field. Moreover, industry-funded research may tend to be published in higher impact, more general journals (Jefferson et al. 2009b ) which will affect the results to some extent, although this would also be true for a field-based classification scheme if industry articles received a citation boost from their presence in higher impact journals.
Although AHFS DI Essentials references include books, reviews, meta-analyses, and other documents the analysis here focuses on standard journal articles because these are the primary vehicle for publishing original research and therefore the most important type of cited document from a research evaluation perspective.
The AHFS DI Essentials documents are not publically available from the originating organisation's website and so they were accessed from Drugs.com instead. The Drugs.com sitemap (https://www.drugs.com/sitemap_index.xml.gz) was used to identify the 2417 AHFS DI Essentials pages in the site (with URLs starting with https://www.drugs.com/ monograph/) and these were downloaded using the free web crawler SocSciBot (socscibot.wlv.ac.uk) on 21 October 2016, using a slow ethical crawl (Thelwall and Stuart 2006) . The references on these pages were extracted using a program added to the free software Webometric Analyst (lexiurl.wlv.ac.uk: Drugs.com: Extract references in the Services menu). The metadata from articles in the ten most cited journals identified in the reference lists was then downloaded from the Scopus website in November 2016, covering the 21 years from 1996 (when Scopus expanded its coverage) to 2016. Only documents of Scopus type Journal Article, excluding reviews, were downloaded. One of the journals, Drugs, had few articles in recent years (most were classified by Scopus as other document types) and so the 11th journal largest was also downloaded as an addition. Scopus was chosen in preference to the Web of Science for its greater coverage of the literature, with the latter essentially forming a subset of the former (Archambault et al. 2009; Moed and Visser 2008) .
The next stage was to match the AHFS DI Essentials references with the Scopus articles for the 11 journals. Although the AHFS DI Essentials references were reasonably standardised, they did not include DOIs, used abbreviated journal names and included many nonstandard documents, making the matching process not straightforward. To ensure accuracy, articles were matched based on PubMed IDs, ignoring articles in AHFS DI Essentials and Scopus without PubMed IDs. Thus, for each journal, two lists of articles were created: one with PubMed IDs and matching a AHFS DI Essentials PubMed ID, and one with PubMed IDs but no matching AHFS DI Essentials PubMed ID. Articles from journals in years with no AHFS DI Essentials references were discarded as unnecessary for the subsequent indicator calculations.
For each journal, the year-normalised average citation count of articles referenced by AHFS DI Essentials was calculated by comparing it to the remaining articles in the journal. The Mean Normalised Log Citation Score (MNLCS) was used for this (Thelwall 2017a ). This calculation is appropriate for individual academic journals because their citations tend to be highly skewed (de Solla Price 1976), following hooked power law distribution (Thelwall 2016a ) and the MNLCS incorporates a logarithmic transformation to eliminate this skewing. MNLCS is preferable to MNCS (Waltman et al. 2011a, b) because of the skewed nature of citation counts, an issue that is also not dealt with by the Relative Citation Ratio (RCR) (Hutchins et al. 2016) . . This calculation is not biased against newer articles because the citation count of each article is normalised against other articles from the same year. Although this gives an advantage to articles published earlier in the year, this should not introduce a source of systematic bias for or against AHFS DI Essentials references. Confidence intervals were calculated using Fieller's (1954) formula for the ratio of two normal distributions, which is a conservative approach because it treats the journal citation average as an estimate rather than a precise value (see also Thelwall 2017b).
Results
For each journal, the year-normalised average number of citations per article is higher than the journal average, and the difference is statistically significant in all cases (Table 1) . Surprisingly, the highest impact general medical journals are at the top of the list and the difference between individual journals is statistically significant for the top journals (as a rule of thumb, if the confidence intervals do not overlap or only overlap a little then the difference is statistically significant). Additional investigations, as described below, were conducted to explore and check the results.
Despite the overall average citation advantage, individual articles referenced by AHFS DI Essentials may still be less cited than average for the publishing journal. For example, 14 of the 336 AHFS-referenced articles in the top journal in Table 1 , The Lancet, had below average citation counts. An examination of these found many that were not standard research articles (Table 2) , explaining their low citation counts. Nevertheless, the prevalence of non-articles within the Lancet Scopus results suggests that the high MNLCS values for AHFS-cited articles in The Lancet in Table 1 may be at least partly due to the presence of non-article document types classified as articles in Scopus within the remainder of the journal (additional manual checks found similar classification errors in some of the remaining articles in this journal). Similar problems occurred in eight of the remaining ten journals (see Appendix, Table 3 ).
The second journal in Table, 1, JAMA, also has papers classified as articles in Scopus that are classified as something else in the JAMA website (Table 3 ). In addition, some JAMA papers that were classified as articles in Scopus and in the JAMA website were not classical journal articles. For example, Typhoid fever (http://jamanetwork.com/journals/ jama/article-abstract/418141) has a subtitle Case Presentation and starts, ''A 35-year-old Maryland woman came to her local hospital on December 4, 1994, complaining of fever and chills for 1 week.'' This is clearly not a traditional medical journal article. Similarly, the two different articles with the same title, ''From the Food and Drug Administration'' (http://jamanetwork.com/journals/jama/article-abstract/418112 and http://jamanetwork. com/journals/jama/article-abstract/415730) are news stories even though they are both labelled ''Article'' by JAMA and Scopus. The first one has subtitle State Contracts for Enforcement of FDA Tobacco Regulations and starts, ''The FDA is contracting with states throughout the country to help enforce requirements of the new tobacco regulation to protect children and adolescents.'' Hence the problem here is the non-standard labelling of outputs by JAMA and copying by Scopus. Antimicrobial Agents and Chemotherapy (Table 4 ) and the Journal of Clinical Oncology (Table 5) do not seem to have non-standard article types classified as articles in Scopus, as confirmed by additional random checks on low cited articles. Thus, these journals give the clearest evidence that articles referenced by AHFS DI Essentials are more highly cited than comparable articles from the same journal. The lists in Tables 4 and 5 also gives concrete evidence that articles useful enough to be references in AHFS DI Essentials do not necessarily attract many Scopus citations.
The higher average citation impact of articles in Journal of Clinical Oncology and Antimicrobial Agents and Chemotherapy that are referenced by AHFS DI Essentials could be (Figs. 1, 2) , it is clear that isolated misclassifications or changes over time cannot explain the impact difference. To further check this, the smallest set of world articles from a single year was investigated in more detail, the 204 articles from 2015 in Antimicrobial Agents and Chemotherapy. All of these were correctly classified as articles, confirming that misclassifications are not a problem for this journal. The shortest article had only two pages (In vitro susceptibility testing of eravacycline is unaffected by medium age and nonstandard assay parameters) but these are labelled in the same way as long form articles and are clearly genuine research articles. This journal allows authors to submit short articles, but both are given equally rigorous reviewing and so it seems reasonable to regard them as equivalent, ''The Short-Form format is intended for the presentation of brief observations that do not warrant full-length papers. Submit Short-Form papers in the same way as full-length papers. They receive the same review, they are not published more rapidly than full-length papers, and they are not considered preliminary communications.'' (http://aac.asm.org/site/misc/ journal-ita_org.xhtml#05). Nevertheless, longer articles tend to be slightly more cited (Pearson correlation 0.220 between page length and the natural log of citation counts plus one) and so it is possible that they are more valuable overall. This cannot explain the AHFS DI Essentials references advantage, however, since in 2015 they have an average length of 5.2 pages, whereas the journal average for the year is 6.3. Thus, the finding for Antimicrobial Agents and Chemotherapy in 2015 is not due to different article types (because there aren't any) or lengths (because AHFS DI Essentials references cite shorter papers but longer papers in the journal tend to be more cited).
Discussion
There are different possible reasons why articles referenced in AHFS DI Essentials tend to be more cited than average for the publishing general or specialist journal. For nine of the eleven examined journals, the reason is at least partly technical: submissions other than articles are classified as articles within Scopus, deflating the average citation count of all articles for the journal and therefore inflating the normalised citation count of genuine articles. A similar phenomenon has previously been observed for entire Scopus categories, with publications in trade journals classified as academic articles (Thelwall 2016b ). For at least two journals in which articles referenced in AHFS DI Essentials are genuinely more highly cited than average, there are several possible explanations. Drugspecific research may be more citable than other medical research. This would explain the higher citation rates for general medical journals but not for specialist journals like Antimicrobial Agents and Chemotherapy (and Drugs). A second possibility is that being mentioned by AHFS DI Essentials gives an article publicity and helps it to generate additional citations. Conversely, more highly cited articles may be more likely to be selected by AHFS DI Essentials since they are more well-known for practical clinical studies. Both of these seem likely to be true to some extent. Unfortunately, it is not possible Article to separate these awareness reasons from the possibility that AHFS DI Essentials references are more useful than typical articles from the publishing journal. The higher citation rates of AHFS DI Essentials references is unsurprising given similar evidence from a source of clinical guidelines (Thelwall and Maflahi 2016) and clinical trials (Thelwall and Kousha 2016) . Since basic medical research seems to be more citable than clinical research (Narin et al. 1976 ) it may be that successful applied (clinical) research tends to be more highly cited than average in medicine. This may occur, for example, because research with practical medical applications (e.g., identifying side- effects or the effects of drugs on breastfeeding or pregnancy) is likely to trigger replication studies as well as follow-up research to check the findings in other contexts, for other diseases and with combinations of drugs. Moreover, other researchers may be inspired to take a similar approach to tackle a related problem. In contrast, it seems possible that more applied research in other areas tends to lead to a specific useful product or idea that is put into practice (e.g., in education) without generating follow-up research. The apparent trend for higher MNLCS values for more recent years (Figs. 1, 2) does not have a clear explanation. Perhaps the most recent additions to AHFS DI Essentials references tend to be articles that more obviously have higher value than articles that have become accepted after a longer period of time.
A limitation of this study is that citations in drug guides should not be taken as definitive evidence of applied medical research value. Even official government sources can use incorrect or inadequate references and in any case may (and probably should) reference high quality systematic reviews, when available, instead of primary sources (Jefferson et al. 2009a) . Moreover, although references in drug guides seem intuitively likely to have informed the advice, no study has definitively proven this and the choice of references may be influenced by national and other biases. Another limitation is that not all articles not cited by AHFS were checked for accurate Scopus classifications as articles. This would be time consuming to do and so only one year was checked (2015 in Antimicrobial Agents and Chemotherapy-see above) to confirm that not all of the results could be the result of misclassifications (or differing paper lengths).
Conclusions
The methods show that it is practical to extract AHFS DI Essentials references as evidence of the applied value of medical research. Since these articles tend to be more highly cited than average for the publishing journal, their extra value may already be recognised by their traditional academic citations, however. Thus, researchers that are concerned with their own citation counts should not be discouraged from attempting to run useful clinical studies.
For individual researchers, an additional practical use of AHFS DI Essentials references is to support a claim for clinical impact (e.g., informing practice, side-effects). At the time of writing, the simplest way to identify such references would be to run a site-specific Google search for the author's last name of the form [name] site:drugs.com/monograph, such as Anakwenze site:drugs.com/monograph. For systematically gathering information for research evaluation exercises, the crawling methods discussed above can be used.
A corollary to the analysis in this study is that those using field normalised citation counts from Scopus for medical areas are likely to get inflated values due to the misclassification of non-articles as articles. This is likely to have affected the UK REF2014, for example. The specialist journal Circulation has classification problems because some (three) of the articles in this journal are not standard journal articles. Several have the now discontinued subtype, Clinical Investigation and Reports, which is probably equivalent to a traditional journal article (Table 7) . Similar classification errors also occurred in some of the remaining articles in this journal. 
